Hello and welcome to the details of Seha expands availability of Pfizer vaccine across the UAE and now with the details
Nevin Al Sukari - Abu Dhabi - Picture used for illustrative purpose only.
Gulf Today, Staff Reporter
Abu Dhabi Health Services Company, (SEHA), the UAE’s largest healthcare network, in collaboration with the Department of Health – Abu Dhabi, has announced the availability of the Pfizer-BioNTech COVID-19 vaccine in all SEHA COVID-19 drive-through services centres and vaccination centres across the country.
The Sinopharm COVID-19 vaccine continues to be available across the network’s facilities and centers.
SEHA stands united with the UAE’s healthcare authorities and partners across the industry to ensure the community have access to vaccinations and is committed to expanding the community’s access to both vaccines.
Both the Pfizer-BioNTech and Sinopharm COVID-19 vaccines are now being administered across 60 centres in Abu Dhabi, Dubai and the Northern Emirates.
Those as young as 12 years old can receive the Pfizer-BioNTech vaccine, while the Sinopharm vaccine is only available to those over the age of 16.
Those exempt from the receiving the vaccine include those who are currently or have recently been infected with COVID-19, volunteers in COVID-19 vaccine clinical trials, pregnant women, people vaccinated outside of the country, those who have severe allergies to vaccines or vaccine components, and members of the community with diseases proven to interact negatively with the vaccine.
These were the details of the news Seha expands availability of Pfizer vaccine across the UAE for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Gulf Today and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.